Rates of chlamydia, gonorrhea, and syphilis increased in the United
States during the past year and continued recent upward trends,
according to a report from the Centers for Disease Control and
Prevention.
"Young women, racial and ethnic populations, and men who have
sex with men are particularly hard hit by these diseases," Dr. John
M. Douglas Jr., director of the CDC's Division of Sexually
Transmitted Disease Prevention, said in a teleconference sponsored by
the CDC.
All three diseases are treatable, especially if diagnosed early. If
left untreated, the severe health consequences include pelvic
inflammatory disease, infertility, increased risk for HIV infection,
organ damage, and death. The direct medical costs associated with STDs
in the United States were estimated at nearly $15 billion in 2006, the
researchers stated in the report, "Sexually Transmitted Disease
Surveillance 2006," which was presented in the telebriefing.
Of the three diseases, the increased chlamydia rates represent the
greatest public health impact, Dr. Douglas said.
The national rate of reported cases of chlamydia increased by 5.6%
from 2005 to 2006, from 329.4 cases per 100,000 persons in 2005 to 347.8
cases in 2006.
Chlamydia hits hardest among adolescent girls and young women--the
highest chlamydia rate was reported in young women aged 15-19 years
(2,863 cases per 100,000 persons), followed by women aged 20-24 years
(2,797 cases). And racial disparity is high: The chlamydia rate among
black women was more than seven times higher that of white women and
more than twice as high as that of Hispanic women.
Given the high rate of chlamydia in young women, the CDC recommends
screening sexually active women younger than 26 years. Chlamydia
screening is also advised for older women with new or multiple sex
partners. Based on recent evidence that chlamydia reinfection can occur
in women whose partners remain untreated, the CDC's treatment
guidelines include retesting patients 3 months after treatment.
Gonorrhea rates increased for the second consecutive year,
following a plateau in reported disease rates from 1997 to 2005.
"The racial disparities are stark" in reported gonorrhea
cases, Dr. Douglas said. Overall, the rate among blacks is 18 times
higher than in whites, he said.
Gonorrhea rates also continue to vary by region. As in previous
years, the southern region of the United States had the highest overall
gonorrhea rate in 2006, at 159 cases per 100,000 persons. But rates in
the South rose by 12.3% in 2006, representing the first notable increase
in 8 years.
"We are also concerned about increases in the West," Dr.
Douglas said. Gonorrhea cases in the West increased by 2.9% between 2005
and 2006, contributing to a 32% increase between 2002 and 2006.
Untreated gonorrhea can, among other complications, increase a
person's risk for HIV if he or she is exposed. But gonorrhea
treatment has become more challenging because evidence of
fluoroquinolone resistance--especially among men who have sex with
men--prompted the CDC in April 2007 to stop recommending
fluoroquinolones as treatment for gonorrhea. As an alternative, the CDC
recommends cephalosporins to treat gonorrhea.
Rates of primary and secondary syphilis in the United States
increased by nearly 14% from 2005 to 2006, but the most notable increase
occurred among men who have sex with men. Syphilis rates among that
group increased by 54% from 2002 to 2006, Dr. Douglas said.
Although syphilis has the least impact on the population as a
whole, the rise in reported cases for the sixth consecutive year is
cause for concern, Dr. Douglas said, given a steady decrease during the
1990s.
The report's data provide an incomplete picture of sexually
transmitted diseases in the United States, the researchers cautioned,
because many cases of chlamydia, gonorrhea, and syphilis are not
reported. In addition, some types of STDs, including genital herpes and
human papillomavirus, are not tracked by the CDC but contribute to the
overall disease burden of STDs, he noted.
The full report is at www.cdc.gov/std/stats.
BY HEIDI SPLETE
Senior Writer
COPYRIGHT 2007 International Medical News
Group Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2007 Gale, Cengage Learning. All rights
reserved. Gale Group is a Thomson Corporation Company.
NOTE: All illustrations and photos have been removed from this article.